DrugPatentWatch Database Preview
Drugs in Development Information for Sulodexide
Email this page to a colleague
» See Plans and PricingWhat is the development status for investigational drug Sulodexide?
Sulodexide is an investigational drug.
There have been 15 clinical trials for Sulodexide.
The most recent clinical trial was a Phase 3 trial, which was initiated on September 1st 2015.
The most common disease conditions in clinical trials are Kidney Diseases, Diabetic Nephropathies, and Albuminuria. The leading clinical trial sponsors are Keryx Biopharmaceuticals, Collaborative Study Group (CSG), and NicOx Research Institute S.r.l.
There are ninety-two US patents protecting this investigational drug and four hundred and forty international patents.
Summary for Sulodexide
| US Patents | 92 |
| International Patents | 440 |
| US Patent Applications | 244 |
| WIPO Patent Applications | 21 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 3 (2015-09-01) |
| Vendors | 6 |
Recent Clinical Trials for Sulodexide
| Title | Sponsor | Phase |
|---|---|---|
| Sulodexide, VESSEL®, for the Prevention of Recurrent Venous Thromboembolism (The Jason Study) | Arianna Anticoagulazione Foundation | Phase 3 |
| Management of Endothelial Dysfunction in Patients With Chronic Venous Insufficiency After Endovenous Surgical Procedure | State Budgetary Healthcare Institution, National Medical Surgical Center N.A. N.I. Pirogov, Ministry of Health of Russia | N/A |
| Rotation for Optimal Targeting of Albuminuria and Treatment Evaluation (ROTATE-2) | University Medical Center Groningen | Phase 4 |
Clinical Trial Summary for Sulodexide
Top disease conditions for Sulodexide
Top clinical trial sponsors for Sulodexide
US Patents for Sulodexide
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Sulodexide | Start Trial | Methods, kits and devices for promoting cardiac regeneration | Yeda Research and Development Co. Ltd. (Rehovot, IL) Victor Chang Cardiac Research Institute (Darlinghurst, AU) | Start Trial |
| Sulodexide | Start Trial | Nucleic acid vaccines | ModernaTX, Inc. (Cambridge, MA) | Start Trial |
| Sulodexide | Start Trial | Polynucleotides encoding immune modulating polypeptides | ModernaTX, Inc. (Cambridge, MA) | Start Trial |
| Sulodexide | Start Trial | Combination PIV3/hMPV RNA vaccines | ModernaTX, Inc. (Cambridge, MA) | Start Trial |
| Sulodexide | Start Trial | Human cytomegalovirus RNA vaccines | ModernaTX, Inc. (Cambridge, MA) | Start Trial |
| Sulodexide | Start Trial | Efficient protein expression in vivo using modified RNA (MOD-RNA) | THE GENERAL HOSPITAL CORPORATION (Boston, MA) CHILDREN'S MEDICAL CENTER CORPORATION (Boston, MA) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Sulodexide
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Sulodexide | Australia | 2015249553 | 2034-04-23 | Start Trial |
| Sulodexide | Brazil | 112016024644 | 2034-04-23 | Start Trial |
| Sulodexide | Canada | 2946751 | 2034-04-23 | Start Trial |
| Sulodexide | China | 106659803 | 2034-04-23 | Start Trial |
| Sulodexide | European Patent Office | 3134131 | 2034-04-23 | Start Trial |
| Sulodexide | Japan | 2017513956 | 2034-04-23 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
